SCHEMBL3978027

SCHEMBL3978027

COc1ccc(C(=O)OC(=O)c2occ(-c3ccccc3)c2-c2ccccc2)c(C(=O)NN)c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.37
POLB P06746 2/20 0.34
TP53 P04637 1/20 0.34
FABP3 P05413 1/20 0.34
FABP4 P15090 1/20 0.34
FABP5 Q01469 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
LMNA P02545 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
PRKCZ Q05513 1/20 0.33
ACLY P53396 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HK2 P52789 1/20 0.33
GRM6 O15303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3974632 0.92 CTSD (0.38) CTSDPOLBTP53FABP3FABP4
SCHEMBL3974207 0.90 ACLY (0.37) CTSDPOLBTP53FABP3FABP4
SCHEMBL3978639 0.90 HTT (0.37) CTSDPOLBTP53FABP3FABP4
SCHEMBL3977002 0.90 POLB (0.37) CTSDPOLBTP53FABP3FABP4
SCHEMBL3982340 0.90 CTSD (0.36) CTSDPOLBTP53FABP3FABP4
SCHEMBL3981082 0.87 MEN1 (0.34) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL3978783 0.87 S1PR1 (0.35) CTSDPOLBTP53FABP3FABP4
SCHEMBL3979544 0.87 HPGD (0.41) CTSDLMNAALDH1A1HTTKDM4E
SCHEMBL3980558 0.87 POLB (0.38) CTSDPOLBTP53LMNAALDH1A1
SCHEMBL3982901 0.86 TP53 (0.33) CTSDPOLBTP53RXFP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 CTSD 2014/4885POLB 4676/4885TP53 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.